Paloma Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-500
Closed -$443K 732
2024
Q3
$443K Sell
500
-300
-38% -$270K 0.01% 663
2024
Q2
$724K Buy
+800
New +$640K 0.02% 607
2024
Q1
Sell
-11,800
Closed -$6.88M 944
2023
Q4
$6.88M Buy
+11,800
New +$6.89M 0.25% 69
2023
Q3
Sell
-11,600
Closed -$5.44M 841
2023
Q2
$5.44M Buy
+11,600
New +$4.86M 0.19% 92
2023
Q1
Sell
-4,700
Closed -$1.72M 883
2022
Q4
$1.72M Buy
4,700
+3,600
+327% +$1.28M 0.08% 251
2022
Q3
$356K Buy
+1,100
New +$349K 0.02% 584
2019
Q4
Sell
-36,800
Closed -$4.12M 2356
2019
Q3
$4.12M Buy
+36,800
New +$4.1M 0.09% 190
2019
Q1
Sell
-11,400
Closed -$1.32M 1818
2018
Q4
$1.32M Buy
+11,400
New +$1.27M 0.04% 371
2018
Q2
Sell
-38,500
Closed -$2.98M 1959
2018
Q1
$2.98M Sell
38,500
-57,500
-60% -$4.63M 0.05% 364
2017
Q4
$8.11M Buy
96,000
+47,000
+96% +$4M 0.11% 150
2017
Q3
$4.19M Hold
49,000
0.06% 342
2017
Q2
$4.03M Buy
49,000
+18,000
+58% +$1.47M 0.05% 396
2017
Q1
$2.61M Buy
+31,000
New +$2.48M 0.03% 629
2016
Q4
Sell
-55,100
Closed -$4.42M 2060
2016
Q3
$4.42M Buy
55,100
+47,100
+589% +$3.77M 0.06% 225
2016
Q2
$630K Hold
8,000
0.01% 1428
2016
Q1
$576K Hold
8,000
0.01% 1232
2015
Q4
$674K Buy
+8,000
New +$664K 0.02% 864

Other funds holding LLY

Paloma Partners's LLY Position: Q3 2024 in Review

Paloma Partners sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 92 shares — an estimated $82.7K sold.

Paloma Partners first reported a position in LLY in Q2 2013 and held it in 34 quarters. The position peaked at $26.2M in Q3 2020. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Paloma Partners reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 92 Eli Lilly shares in Q3 2024, an estimated $82.7K.
  • Paloma Partners first reported a position in Eli Lilly in Q2 2013 and held it in 34 quarters.
  • Paloma Partners's Eli Lilly position peaked at $26.2M in Q3 2020.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.